tiprankstipranks
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ:ZVRA
US Market
Want to see ZVRA full AI Analyst Report?

Zevra Therapeutics (ZVRA) Technical Analysis

1,095 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Zevra Therapeutics, Inc.’s (ZVRA) Moving Averages Convergence Divergence (MACD) indicator is 0.63, suggesting Zevra Therapeutics, Inc. is a Sell.
Zevra Therapeutics, Inc.’s (ZVRA) 20-Day exponential moving average is 11.67, while Zevra Therapeutics, Inc.’s (ZVRA) share price is $10.67, making it a Buy.
Zevra Therapeutics, Inc.’s (ZVRA) 50-Day exponential moving average is 10.87, while Zevra Therapeutics, Inc.’s (ZVRA) share price is $10.67, making it a Buy.

Zevra Therapeutics (ZVRA) Pivot Points

Jun 14, 2026, 08:44 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.85
12.27
12.62
13.03
13.38
13.80
14.15
Fibonacci
12.27
12.56
12.74
13.03
13.33
13.51
13.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zevra Therapeutics (ZVRA) Moving Averages

Jun 14, 2026, 08:44 PM
Period
Simple
Exponential
MA5
12.97Sell
12.68Sell
MA10
12.00Buy
12.23Buy
MA20
11.33Buy
11.67Buy
MA50
10.71Buy
10.87Buy
MA100
9.90Buy
10.28Buy
MA200
9.52Buy
10.01Buy
Zevra Therapeutics, Inc.’s (ZVRA) 10-Day exponential moving average is 12.23, while Zevra Therapeutics, Inc.’s (ZVRA) share price is $10.67, making it a Buy.
Zevra Therapeutics, Inc.’s (ZVRA) 100-Day exponential moving average is 10.28, while Zevra Therapeutics, Inc.’s (ZVRA) share price is $10.67, making it a Buy.
Zevra Therapeutics, Inc.’s (ZVRA) stock price is $10.67 and Zevra Therapeutics, Inc.’s (ZVRA) 50-day simple moving average is 10.71, creating a Buy signal.
Zevra Therapeutics, Inc.’s (ZVRA) stock price is $10.67 and Zevra Therapeutics, Inc.’s (ZVRA) 100-day simple moving average is 9.90, creating a Buy signal.
Zevra Therapeutics, Inc.’s (ZVRA) stock price is $10.67 and Zevra Therapeutics, Inc.’s (ZVRA) 200-day simple moving average is 9.52, creating a Buy signal.

Zevra Therapeutics (ZVRA) Technical Indicators

Jun 14, 2026, 08:44 PM
Name
Value
Implied Action
RSI (14)
60.36
Neutral
STOCH (9,6)
68.58
Neutral
STOCHRSI (14)
70.98
Neutral
MACD (12,26)
0.63
Sell
ADX (14)
31.30
Neutral
Williams %R
-38.48
Buy
CCI (14)
130.75
Sell
ATR (14)
0.78
-
Ultimate Oscillator
52.01
Neutral
ROC
26.12
Buy
Zevra Therapeutics, Inc.’s (ZVRA) Relative Strength Index (RSI) is 60.36, creating a Neutral signal.
Zevra Therapeutics, Inc.’s (ZVRA) Trend Strength Indicator (ADX) is 31.30, creating a Neutral signal.
Zevra Therapeutics, Inc.’s (ZVRA) Commodity Channel Index (CCI) is 130.75, creating a Sell signal.
Zevra Therapeutics, Inc.’s (ZVRA) Price Rate of Change (ROC) is 26.12, creating a Buy signal.

FAQ

Is ZVRA a Buy, Hold, or Sell?
Based on ZVRA’s technical indicators, ZVRA is a Buy.
    What is ZVRA’s RSI (14)?
    ZVRA’s RSI (14) is 60.36, which suggests ZVRA is a Neutral.
      What is ZVRA’s MACD?
      ZVRA’s MACD is 0.63, which suggests ZVRA is a Sell.
        What is ZVRA’s 5-day moving average?
        ZVRA’s 5-day moving average is 12.97, which suggests ZVRA is a Sell.
          What is ZVRA’s 20-day moving average?
          ZVRA 20-day moving average is 11.33, which suggests ZVRA is a Buy.
            What is ZVRA’s 50-day moving average?
            ZVRA’s 50-day moving average is 10.71, which suggests ZVRA is a Buy.
              What is ZVRA’s 200-day moving average?
              ZVRA’s 200-day moving average is 9.52, which suggests ZVRA is a Buy.
                What is ZVRA’s Williams % R (14)?
                ZVRA’s Williams % R (14) is -38.48, which suggests ZVRA is a Buy.
                  What is ZVRA’s CCI (14)?
                  ZVRA’s CCI (14) is 130.75, which suggests ZVRA is a Sell.